NICE has said the Alzheimer's disease drug is too expensive to be available on the NHS, but researchers are now hoping to ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

If I were a statistician tucked away in an NHS backroom, I might well curse the day the health service was founded. There, on ...

Donanemab: Everything we know about the latest Alzheimer’s drug rejected by the NHS - Donanemab and another new drug for ...

There have been many promising leads for an Alzheimer's vaccine but new treatments have been slow to merge. Researchers at ...

It marks the second such rejection in the UK for an Alzheimer’s treatment, after Eisai and Biogen’s drug met the same fate ...

TV presenter Ruth Langsford has said she is afraid of developing Alzheimer’s disease after seeing both her parents develop ...

Eli Lilly's donanemab receives UK approval for mild cognitive impairment and mild dementia due to Alzheimer's disease.

Donanemab marks a significant advancement in Alzheimer’s treatment, but NHS patients face a setback with NICE's rejection of ...

Eli Lilly’s Alzheimer’s disease offering Kinsunla is poised to face a tough road ahead in the U.K. | Lilly's Alzheimer ...

A wife whose husband will not be eligible for new Alzheimer’s drugs has implored health leaders to ensure that others like ...

The UK’s healthcare spending watchdog has rejected Eli Lilly’s (LLY) Alzheimer’s drug as being too expensive despite being ...